Claims Scope:

Patent Issued November 27, 2023. 

80% Sequence Identity  

Vector encoding shRNA targeting endogenous, defective forms of PAH and expressing wild-type PAH; shRNAs having at least 80% identity to SEQ ID Nos: 3 or 4.